The investigation of serum phenylalanine levels based on infant feeding method: a cross-sectional study of children less than two years old with phenylketonuria (PKU)

Zaniar Mohammadzadeh,Loghman Sharifi,Asadolah Fatholahpour,Elham Bazshahi

DOI: https://doi.org/10.1186/s13006-024-00617-0

2024-02-15

International Breastfeeding Journal

Abstract:Clinical advice may suggest discontinuing breastfeeding after the diagnosis of phenylketonuria in infants as the only effective way to monitor the newborn's intake and accurate measurement of phenylalanine (Phe). This study aims to investigate the prevalence and duration of breastfeeding, as well as its effect on serum Phe levels in infants with phenylketonuria at Education and Therapy Medical Center, Be'sat Hospital, Iran.

pediatrics,obstetrics & gynecology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the effects of breastfeeding and non - breastfeeding on the serum phenylalanine levels and growth indicators of infants with phenylketonuria (PKU). Specifically, the study aims to investigate the prevalence and duration of breastfeeding in PKU infants and compare the effects of breastfeeding and non - breastfeeding on serum phenylalanine levels and anthropometric indicators (such as body weight, height and head circumference). This study was conducted in Iran, and no similar studies had been reported in this region before.

### Research Background
Phenylketonuria (PKU) is an autosomal recessive inborn error of metabolism. Due to mutations in the phenylalanine hydroxylase gene, enzyme defects in the phenylalanine metabolic pathway are caused, resulting in an increase in phenylalanine concentration in the blood and central nervous system. Untreated PKU can lead to symptoms such as intellectual disability, learning difficulties, spasticity, epileptic seizures, developmental delay and congenital heart disease. Newborn screening is helpful for early identification and treatment of these metabolic diseases, reducing morbidity and mortality.

### Research Objectives
1. **Investigate the prevalence and duration of breastfeeding**: Understand the situation of breastfeeding in PKU infants.
2. **Compare the effects of breastfeeding and non - breastfeeding on serum phenylalanine levels**: Evaluate the differences in serum phenylalanine levels between different feeding methods.
3. **Evaluate the effects of breastfeeding and non - breastfeeding on growth indicators**: Compare growth indicators such as body weight, height and head circumference of infants in the two groups.

### Methods
The study adopted a cross - sectional design and analyzed the medical records of 34 PKU infants under two years old who received treatment at the Besat Hospital Education and Treatment Center in Kurdistan Province, Iran from September 2018 to December 2022. The study subjects were divided into a breastfeeding group and a non - breastfeeding group according to the feeding method after diagnosis. Data collection included age, gender, parental consanguinity, annual family income, mother's education level, place of residence, anthropometric indicators at birth and final assessment, serum phenylalanine levels, etc.

### Results
- **Prevalence and duration of breastfeeding**: 38% of the infants continued breastfeeding, with an average duration of 2.57 ± 0.59 months.
- **Serum phenylalanine levels**: The serum phenylalanine level in the non - breastfeeding group was slightly lower than that in the breastfeeding group, but the difference was not statistically significant (t(34) = 118.0, P = 0.51).
- **Growth indicators**: There were no significant differences between the two groups of infants in terms of body weight, height and head circumference, and all indicators were within the normal range.

### Conclusions
The research results show that during the treatment of PKU infants, there are no significant differences in serum phenylalanine levels and growth indicators between breastfeeding and non - breastfeeding. This indicates that through appropriate control of serum phenylalanine levels, breastfeeding can be part of the treatment of PKU infants, and at the same time, it helps to strengthen the emotional connection between mother and infant, and improve the acceptance of the disease and treatment compliance.